Global Buprenorphine Hydrochloride Market

Buprenorphine Hydrochloride Comprehensive Study by Type (Tablet, Capsule), Application (Analgesic, Opioid Antagonist), Distribution Channel (Online Pharma, Hospital pharma, Retail Pharma) Players and Region - Global Market Outlook to 2026

Buprenorphine Hydrochloride Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Buprenorphine Hydrochloride Market Scope
Buprenorphine hydrochloride is a semisynthetic opioid analgesic that comes as a white crystalline powder and is used to treat mild to extreme pain. Morphine, codeine, and methamphetamine are all members of the same chemical family. Buprenorphine hydrochloride, on the other hand, has the advantage of having less euphoric effects than those medications. Buprenorphine Hydrochloride is the hydrochloride salt of buprenorphine, a narcotic analgesic synthetic phenanthrene. In the central nervous system, buprenorphine hydrochloride is a partial agonist at the mu-opioid receptor and an antagonist at the kapa-opioid receptor.

AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)
Key Companies ProfiledSiegfried (Switzerland), Sanofi (France), Johnson Matthey (United Kingdom), Mallinckrodt (United Kingdom), Noramco (United States), Unichemlabs (India), Arevipharma (Germany), Resonance-labs (India), Sun Pharma (India) and Rusan Pharma (India)
CAGR%


There are various companies that are operating in the new geographical regions by adopting various market growth initiatives such as mergers & acquisitions, expansions, investments, and others. There are various new market players are entering the market to capture market growth opportunities. Research Analyst at AMA estimates that Indian Players will contribute to the maximum growth of Global Buprenorphine Hydrochloride market throughout the predicted period.

Siegfried (Switzerland), Sanofi (France), Johnson Matthey (United Kingdom), Mallinckrodt (United Kingdom), Noramco (United States), Unichemlabs (India), Arevipharma (Germany), Resonance-labs (India), Sun Pharma (India) and Rusan Pharma (India) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Micro Orgo Chem (India) and Faranshimi (Iran).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Buprenorphine Hydrochloride market by Type , by Application (Analgesic and Opioid Antagonist) and Region with country level break-up.

On the basis of geography, the market of Buprenorphine Hydrochloride has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2021.




Influencing Trend:
Increasing Surgical Procedures and Technological Advancements

Market Growth Drivers:
Increasing Road Accidents. and Growing Occurrence of Chronic Pain.

Challenges:
Stringent Government Regulations

Restraints:
Continues Products Development and R&D has Introduced Number of Cheaper Substitutes

Opportunities:
Growing Palliative Care Facilities Boost the Buprenorphine Hydrochloride Market.

Key Target Audience
Pharmaceutical Companies, Healthcare Industry, Regulatory Bodies, Research Institutions and Others

Report Objectives / Segmentation Covered

By Type
  • Tablet
  • Capsule
By Application
  • Analgesic
  • Opioid Antagonist
By Distribution Channel
  • Online Pharma
  • Hospital pharma
  • Retail Pharma

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Road Accidents.
      • 3.2.2. Growing Occurrence of Chronic Pain.
    • 3.3. Market Challenges
      • 3.3.1. Stringent Government Regulations
    • 3.4. Market Trends
      • 3.4.1. Increasing Surgical Procedures and Technological Advancements
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
  • 5. Global Buprenorphine Hydrochloride, by Type, Application, Distribution Channel and Region (value) (2016-2021)
    • 5.1. Introduction
  • 6. Buprenorphine Hydrochloride: Manufacturers/Players Analysis
    • 6.1. Company Profile
      • 6.1.1. Siegfried (Switzerland)
        • 6.1.1.1. Business Overview
        • 6.1.1.2. Products/Services Offerings
        • 6.1.1.3. Financial Analysis
        • 6.1.1.4. SWOT Analysis
      • 6.1.2. Sanofi (France)
        • 6.1.2.1. Business Overview
        • 6.1.2.2. Products/Services Offerings
        • 6.1.2.3. Financial Analysis
        • 6.1.2.4. SWOT Analysis
      • 6.1.3. Johnson Matthey (United Kingdom)
        • 6.1.3.1. Business Overview
        • 6.1.3.2. Products/Services Offerings
        • 6.1.3.3. Financial Analysis
        • 6.1.3.4. SWOT Analysis
      • 6.1.4. Mallinckrodt (United Kingdom)
        • 6.1.4.1. Business Overview
        • 6.1.4.2. Products/Services Offerings
        • 6.1.4.3. Financial Analysis
        • 6.1.4.4. SWOT Analysis
      • 6.1.5. Noramco (United States)
        • 6.1.5.1. Business Overview
        • 6.1.5.2. Products/Services Offerings
        • 6.1.5.3. Financial Analysis
        • 6.1.5.4. SWOT Analysis
      • 6.1.6. Unichemlabs (India)
        • 6.1.6.1. Business Overview
        • 6.1.6.2. Products/Services Offerings
        • 6.1.6.3. Financial Analysis
        • 6.1.6.4. SWOT Analysis
      • 6.1.7. Arevipharma (Germany)
        • 6.1.7.1. Business Overview
        • 6.1.7.2. Products/Services Offerings
        • 6.1.7.3. Financial Analysis
        • 6.1.7.4. SWOT Analysis
      • 6.1.8. Resonance-labs (India)
        • 6.1.8.1. Business Overview
        • 6.1.8.2. Products/Services Offerings
        • 6.1.8.3. Financial Analysis
        • 6.1.8.4. SWOT Analysis
      • 6.1.9. Sun Pharma (India)
        • 6.1.9.1. Business Overview
        • 6.1.9.2. Products/Services Offerings
        • 6.1.9.3. Financial Analysis
        • 6.1.9.4. SWOT Analysis
      • 6.1.10. Rusan Pharma (India)
        • 6.1.10.1. Business Overview
        • 6.1.10.2. Products/Services Offerings
        • 6.1.10.3. Financial Analysis
        • 6.1.10.4. SWOT Analysis
  • 7. Global Buprenorphine Hydrochloride Sale, by Type, Application, Distribution Channel and Region (value) (2022-2027)
    • 7.1. Introduction
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Company Basic Information, Sales Area and Its Competitors
  • Table 2. Company Basic Information, Sales Area and Its Competitors
  • Table 3. Company Basic Information, Sales Area and Its Competitors
  • Table 4. Company Basic Information, Sales Area and Its Competitors
  • Table 5. Company Basic Information, Sales Area and Its Competitors
  • Table 6. Company Basic Information, Sales Area and Its Competitors
  • Table 7. Company Basic Information, Sales Area and Its Competitors
  • Table 8. Company Basic Information, Sales Area and Its Competitors
  • Table 9. Company Basic Information, Sales Area and Its Competitors
  • Table 10. Company Basic Information, Sales Area and Its Competitors
  • Table 11. Research Programs/Design for This Report
  • Table 12. Key Data Information from Secondary Sources
  • Table 13. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Siegfried (Switzerland) Revenue, Net Income and Gross profit
  • Figure 5. Siegfried (Switzerland) Revenue: by Geography 2021
  • Figure 6. Sanofi (France) Revenue, Net Income and Gross profit
  • Figure 7. Sanofi (France) Revenue: by Geography 2021
  • Figure 8. Johnson Matthey (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 9. Johnson Matthey (United Kingdom) Revenue: by Geography 2021
  • Figure 10. Mallinckrodt (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 11. Mallinckrodt (United Kingdom) Revenue: by Geography 2021
  • Figure 12. Noramco (United States) Revenue, Net Income and Gross profit
  • Figure 13. Noramco (United States) Revenue: by Geography 2021
  • Figure 14. Unichemlabs (India) Revenue, Net Income and Gross profit
  • Figure 15. Unichemlabs (India) Revenue: by Geography 2021
  • Figure 16. Arevipharma (Germany) Revenue, Net Income and Gross profit
  • Figure 17. Arevipharma (Germany) Revenue: by Geography 2021
  • Figure 18. Resonance-labs (India) Revenue, Net Income and Gross profit
  • Figure 19. Resonance-labs (India) Revenue: by Geography 2021
  • Figure 20. Sun Pharma (India) Revenue, Net Income and Gross profit
  • Figure 21. Sun Pharma (India) Revenue: by Geography 2021
  • Figure 22. Rusan Pharma (India) Revenue, Net Income and Gross profit
  • Figure 23. Rusan Pharma (India) Revenue: by Geography 2021
List of companies from research coverage that are profiled in the study
  • Siegfried (Switzerland)
  • Sanofi (France)
  • Johnson Matthey (United Kingdom)
  • Mallinckrodt (United Kingdom)
  • Noramco (United States)
  • Unichemlabs (India)
  • Arevipharma (Germany)
  • Resonance-labs (India)
  • Sun Pharma (India)
  • Rusan Pharma (India)
Additional players considered in the study are as follows:
Micro Orgo Chem (India) , Faranshimi (Iran)
Select User Access Type

Key Highlights of Report


Apr 2021 206 Pages 63 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Buprenorphine Hydrochloride Market Quantitative research analysis
Global Buprenorphine Hydrochloride Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Buprenorphine Hydrochloride Market are by type [Tablet and Capsule], by end use application [Analgesic and Opioid Antagonist].
The Buprenorphine Hydrochloride Market is gaining popularity and expected to see strong valuation by 2027.
  • Increasing Road Accidents.
  • Growing Occurrence of Chronic Pain.

Know More About Global Buprenorphine Hydrochloride Market Report?

Have a Query? Click Here

Other Related Reports

Poliomyelitis Vaccine Comprehensive Study by Type (Oral Polio Vaccine (OPV), Inactivated Poliomyelitis Vaccine (IPV)), Application (Hospital, Clinics, Public Services, Others), Route of Administratio...
$ 3450
Measles Vaccine Comprehensive Study by Type (Mumps Measles Rubella Vaccine, Live (MMR-II), Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)), Application (Pediatric Vaccines, Adult Vaccine...
$ 3450
Meningococcal Vaccines Comprehensive Study by Type (Polysaccharide Vaccines, Conjugate Vaccines, Combination Vaccines, Others), Application (Pneumonia, Meningitis, Bacteremia, Others (Arthritis, Conj...
$ 3750
Asthma Treatment Drugs Comprehensive Study by Type (Long-term Control Medications, Quick-relief Medications (Rescue Medications), Medications for Allergy-induced Asthma), Application (Hospital Pharma...
$ 3750
Nevirapine Comprehensive Study by Type (100 mg, 200 mg, 400 mg), Application (Women (Pregnant, Non- pregnant), Men), Method (Antiretroviral Therapy, Hepatotoxicity) Players and Region - Global Market...
$ 3500
Medication Adherence Packaging Systems Comprehensive Study by Type (Unit-dose Packaging Systems, Multi-dose Packaging Systems), Packaging (Ampoules, Vials, Prefilled Syringes & Injectable, Blisters, ...
$ 3750